antibody fragments

Boehringer Ingelheim collaborates with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy
Pharmaceutical Business Review
Thu, 05/14/20 - 11:59 am
Boehringer Ingelheim
CDR-Life
antibody fragments
geographic atrophy
R&D